Augustin, M., Wegtowska, J., Lebwohl, M., Paul, C., Piguet, V., Sofen, H., Blauvelt, A., Peterson, L., & al., E. (2018). Durability of Response in Patients with Chronic Plaque Psoriasis Treated with Certolizumab Pegol over 48 Weeks: Pooled Results from Ongoing Phase 3, Multicenter, Randomized, Placebo-Controlled Studies (CIMPASI-1, CIMPASI-2 and CIMPACT). SKIN The Journal of Cutaneous Medicine, 2, S87.